# The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients

> **NCT06173817** · PHASE1 · WITHDRAWN · sponsor: **Oslo University Hospital**

## Conditions studied

- Methanol Poisoning

## Interventions

- **DEVICE:** isocapnic hyperventilation

## Key facts

- **NCT ID:** NCT06173817
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-01-29
- **Primary completion:** 2026-01-29
- **Final completion:** 2026-01-29
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Difficulties in working across borders due to sanctions
- **Last updated:** 2026-02-11

## Collaborators

- Loghman-Hakim Hospital, Teheran, Iran
- Shohada-e-Tajrish Hospital, Teheran, Iran
- Baharloo Hospital, Teheran, Iran
- Imam Reza Hospital, Mashhad University of Medical Sciences, Iran
- Khorshid Hospital, Isfahan University of Medical Sciences, Iran

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06173817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06173817, "The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06173817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*